糖尿病与低体重指数对结核病治疗转归的影响
在印度金奈开展的前瞻性队列研究比较了389例肺结核患者(256例糖尿病,133例糖耐量正常),发现低BMI(<18.5 kg/m2)与不良治疗结局风险增加显著相关,而合并控制不佳的糖尿病反而降低该风险,高内脏脂肪指数与不良结局相关。
要点
- 低BMI患者影像学病变最重、痰培养转阴时间最长、治疗失败和死亡 rates 最高。
- 在正常或高BMI者中,治疗结局不因血糖状态而异。
- 低BMI者中,控制不佳的糖尿病(HbA1c≥8.0%)意外与更好的结核治疗结局相关。
核心结论
- 低BMI与结核不良治疗结局风险增加显著相关,而合并控制不佳的糖尿病反而降低该风险。
- 高内脏脂肪指数可能反映与脂肪组织功能障碍相关的新型结核易感机制。
研究设计与样本
- 前瞻性队列研究(Effects of Diabetes on Tuberculosis Severity研究),在印度金奈比较成人肺结核患者。
- 队列共389例参与者,包括256例糖尿病和133例糖耐量正常者。
主要发现
- 低BMI(<18.5 kg/m2)见于99例(74.4%)非糖尿病参与者和85例(33.2%)糖尿病参与者。
- 低BMI参与者影像学疾病严重程度最高、痰培养转阴时间最长、治疗失败和死亡 rates 最高。
- 在正常或高BMI参与者中,治愈、治疗失败或死亡 rates 不因血糖状态而异。
- 低BMI者中,控制不佳的糖尿病(HbA1c≥8.0%)意外与更好的结核治疗结局相关。
- 高内脏脂肪指数与不良结局相关,且部分低BMI糖耐量正常者该指数升高。
关键数值与推荐
- 低BMI定义为<18.5 kg/m2。
- 控制不佳的糖尿病定义为HbA1c≥8.0%。
临床怎么用
- 对肺结核患者应评估BMI,低BMI者需警惕治疗失败和死亡风险升高。
- 低BMI合并糖尿病者,不应仅因血糖控制不佳而预期更差结局,需综合评估内脏脂肪等因素。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes was identified as a tuberculosis (TB) risk factor mostly in retrospective studies with limited assessments of metabolic variables. The prospective Effects of Diabetes on Tuberculosis Severity study compared adults with pulmonary TB in Chennai, India, who were classified as having either diabetes or a normal glucose tolerance at enrollment. METHODS: Baseline TB severity, sputum conversion, and treatment outcomes (cure, failure, death, or loss to follow-up) were compared between groups with respect to glycemic status and body mass index (BMI). RESULTS: The cohort of 389 participants included 256 with diabetes and 133 with a normal glucose tolerance. Low BMIs (<18.5 kg/m2) were present in 99 (74.4%) of nondiabetic participants and 85 (33.2%) of those with diabetes. Among participants with normal or high BMIs, rates of cure, treatment failure, or death did not vary by glycemic status. Participants with low BMIs had the highest radiographic severity of disease, the longest time to sputum culture conversion, and the highest rates of treatment failure and death. Among participants with low BMIs, poorly controlled diabetes (glycohemoglobin [HbA1c] ≥8.0%) was unexpectedly associated with better TB treatment outcomes. A high visceral adiposity index was associated with adverse outcomes and, despite an overall correlation with HbA1c, was elevated in some low-BMI individuals with normal glucose tolerance. CONCLUSIONS: In this South Indian cohort, a low BMI was significantly associated with an increased risk for adverse TB treatment outcomes, while comorbid, poorly controlled diabetes lessened that risk. A high visceral adiposity index, either with or without dysglycemia, might reflect a novel TB susceptibility mechanism linked to adipose tissue dysfunction.
引用
- Kornfeld H, Sahukar SB, Procter-Gray E, et al. Impact of Diabetes and Low Body Mass Index on Tuberculosis Treatment Outcomes. Clin Infect Dis. 2020. PMID: 31955202. doi:10.1093/cid/ciaa054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。